South & Central America Structural Heart Market Forecast to 2028

South & Central America Structural Heart Market Forecast to 2028 – Regional Analysis – by Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others), Procedure (Heart Valve Stenosis, Heart Valve Regurgitation, and Left Atrial Appendage Closure), and End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers)

Send Enquiry
Item ID: BMIRE00028949 Category: Tags: , ,

$2,100$3,500

Description

The South & Central America structural heart market is expected to grow from US$ 770.68 million in 2023 to US$ 1,148.35 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to 2028.

Rising Number of Cardiovascular Disease Cases and Training Programs Fuel South & Central America Structural Heart Market

According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death South & Central America. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice.

South & Central America Structural Heart Market Overview

The South and Central America structural heart is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to register the largest market share in this region during the forecast period. The flourishing medical tourism sector and growing government initiatives to create awareness about modern healthcare products are the factors contributing to the structural heart market growth in South & Central America. Additionally, the rising prevalence of cardiovascular diseases and hypertension is propelling the structural heart market growth in the region.

South & Central America Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Structural Heart Market Segmentation

The South & Central America structural heart market is segmented into product, procedure, end user, and country.

Based on product, the South & Central America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the South & Central America structural heart market in 2022.

Based on procedure, the South & Central America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the South & Central America structural heart market in 2022.

Based on end user, the South & Central America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the South & Central America structural heart market in 2022.

Based on country, the South & Central America structural heart market is segmented into the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Braile Biomedica Industry, Commerce and Representations Ltd are some of the leading companies operating in the South & Central America structural heart market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 6.9% CAGR, the South & Central America Structural Heart Market is Speculated to be Worth US$ 1,148.35 million by 2028, says Business Market Insights

According to Business Market Insights research, the South & Central America structural heart market was valued at US$ 770.68 million in 2022 and is expected to reach US$ 1,148.35 million by 2028, registering a CAGR of 6.9% from 2022 to 2028. Availability of innovative structural heart services and rise in the number of cardiovascular diseases and training programs are the factors attributed to the South & Central America structural heart market expansion.

The availability of technologically advanced products and treatment services allows surgeons, physicians, and other healthcare providers to offer superior services to their patients, which helps them maintain the optimum quality of life. The innovations are not limited to healthcare facilities, and they are extended to programs that are being designed for patients to get benefits out of treatment facilities. Heart diseases are complex, and the success of their intervention depends on innovations bringing treatment options that were deemed impossible earlier into reality. The heart disease treatment landscape—from structural inventions to surgical valve therapies—has experienced breakthrough innovations over the past few decades. Companies in the South & Central America Structural heart market offer a broad portfolio of solutions for different heart conditions, including vascular disease, irregular heartbeats, and heart valve diseases. Physicians can now manage arrhythmias by using remote monitoring devices to keep a tab on their patients, thereby treating an array of structural heart conditions. The food and Drug Administration (FDA) have approved various therapies that are limited to the selected groups the patients. For instance, Premier Health, one of the providers of innovative structural heart services, offers alcohol septal ablation treatment for hypertrophic cardiomyopathy. The treatment mainly uses a catheter-based technology. The balloon valvuloplasty, uses a transcatheter approach for widening up stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart’s left and right atrium without surgery and such more services are being provided by the service providers. CentraCare’s Heart & Vascular Center used EchoPixel’s True3D and HTG pre-planning software, which provides mixed reality capabilities that allow structural heart care teams to interact with a real-time holographic version of the patient’s anatomy without physically touching it or exposing it to contrast agents and radiations. In August 2021, the first 3D-printed heart valve of an Indian make was developed in Chennai. The innovative technologies and techniques of structural heart programs are specifically designed to provide quality care for the best results for patients and provides less complications and shorter recovery times with long-lasting advantages. Such technologies are likely to attract more patients suffering from the structural heart diseases and eventually the benefits of the services are likely to enhance the growth of the market in the forecasted period.

On the contrary, high cost of procedures hampers the South & Central America structural heart market.

Based on product, the South & Central America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held 39.7% share of South & Central America structural heart market in 2022, amassing US$ 306.15 million. It is projected to garner US$ 462.71 million by 2028 to expand at 7.1% CAGR during 2022-2028.

Based on procedure, the South & Central America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held 39.6% share of South & Central America structural heart market in 2022, amassing US$ 305.13 million. It is projected to garner US$ 469.05 million by 2028 to expand at 7.4% CAGR during 2022-2028.

Based on end user, the South & Central America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 46.0% share of South & Central America structural heart market in 2022, amassing US$ 354.75 million. It is projected to garner US$ 541.66 million by 2028 to expand at 7.3% CAGR during 2022-2028.

Based on country, the South & Central America structural heart market has been categorized into the Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that the Brazil captured 61.4% share of South & Central America structural heart market in 2022. It was assessed at US$ 473.23 million in 2022 and is likely to hit US$ 708.72 million by 2028, exhibiting a CAGR of 7.0% during 2022-2028.

Key players operating in the South & Central America structural heart market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, Braile Biomedica Industry, and Commerce and Representations Ltd, among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Structural Heart Market – by Product
1.3.2 South & Central America Structural Heart Market – by Procedure
1.3.3 South & Central America Structural Heart Market – by End User
1.3.4 South & Central America Structural Heart Market – by Country
2. South & Central America Structural Heart Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Structural Heart Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. South & Central America Structural Heart Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Availability of Innovative Structural Heart Services
5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
5.2.1 High Cost of Procedures
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis
6. Structural Heart Market – South & Central America Analysis
6.1 South & Central America Structural Heart Market Revenue Forecast and Analysis
7. South & Central America Structural Heart Market – Revenue and Forecast to 2028 – by Product
7.1 Overview
7.2 South & Central America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
7.3.1 Overview
7.3.2 Occluders: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
7.4.1 Overview
7.4.2 Annuloplasty Rings: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
7.5.1 Overview
7.5.2 Heart Valve Balloons: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Structural Heart Market – Revenue and Forecast to 2028 – by Procedure
8.1 Overview
8.2 South & Central America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
8.3.1 Overview
8.3.2 Heart Valve Stenosis: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
8.4.1 Overview
8.4.2 Heart Valve Regurgitation: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
8.5.1 Overview
8.5.2 Left Atrial Appendage Closure: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Structural Heart Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 South & Central America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
9.5.1 Overview
9.5.2 Cardiac Centers: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Structural Heart Market – Revenue and Forecast to 2028 -Country Analysis
10.1 South & Central America South & Central America Structural Heart Market
10.1.1 Overview
10.1.2 South & Central America: South & Central America Structural Heart Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Brazil: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 Brazil: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.1.4 Brazil: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.1.4.1 Brazil: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.1.4.2 Brazil: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.1.5 Brazil: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.2.2 Argentina: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Argentina: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Argentina: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.2.4 Argentina: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.2.4.1 Argentina: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.2.4.2 Argentina: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.2.5 Argentina: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.2.3 Rest of South & Central America: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South & Central America: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Rest of South & Central America: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.3.4 Rest of South & Central America: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.3.4.1 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.3.4.2 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.3.5 Rest of South & Central America: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
11. South & Central America Structural Heart Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Artivion Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica Industry, Commerce and Representations Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Brazil South & Central America Structural Heart Market, by Product – Revenue and forecast to 2028 (USD Million)
Table 2. Brazil South & Central America Structural Heart Market, by Procedure – Revenue and forecast to 2028 (USD Million)
Table 3. Brazil South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and forecast to 2028 (USD Million)
Table 4. Brazil South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and forecast to 2028 (USD Million)
Table 5. Brazil South & Central America Structural Heart Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 6. Argentina South & Central America Structural Heart Market, by Product – Revenue and forecast to 2028 (USD Million)
Table 7. Argentina South & Central America Structural Heart Market, by Procedure – Revenue and forecast to 2028 (USD Million)
Table 8. Argentina South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and forecast to 2028 (USD Million)
Table 9. Argentina South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and forecast to 2028 (USD Million)
Table 10. Argentina South & Central America Structural Heart Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 11. Rest of South & Central America South & Central America Structural Heart Market, by Product – Revenue and forecast to 2028 (USD Million)
Table 12. Rest of South & Central America South & Central America Structural Heart Market, by Procedure – Revenue and forecast to 2028 (USD Million)
Table 13. Rest of South & Central America South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and forecast to 2028 (USD Million)
Table 14. Rest of South & Central America South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and forecast to 2028 (USD Million)
Table 15. Rest of South & Central America South & Central America Structural Heart Market, by End User – Revenue and forecast to 2028 (USD Million)
Table 16. Recent Organic Growth Strategies in South & Central America Structural Heart Market
Table 17. Glossary of Terms

LIST OF FIGURES

Figure 1. South & Central America Structural Heart Market Segmentation
Figure 2. South & Central America Structural Heart Market, by Country
Figure 3. South & Central America Structural Heart Market Overview
Figure 4. Occluders Segment Held Largest Share of Product Segment in South & Central America Structural Heart Market
Figure 5. South & Central America: PEST Analysis
Figure 6. South & Central America Structural Heart Market Experts’ Opinion
Figure 7. South & Central America Structural Heart Market: Impact Analysis of Drivers and Restraints
Figure 8. South & Central America Structural Heart Market – Revenue Forecast and Analysis – 2019-2028
Figure 9. South & Central America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
Figure 10. .Occluders: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Annuloplasty Rings: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Heart Valve Balloons: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. South & Central America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
Figure 15. Heart Valve Stenosis: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Heart Valve Regurgitation: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Left Atrial Appendage Closure: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. South & Central America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
Figure 19. Hospitals: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ambulatory Surgical Centers: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Cardiac Centers: South & Central America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. South & Central America: South & Central America Structural Heart Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23. Brazil South & Central America Structural Heart Market Revenue and Forecast to 2028 (USD Million)
Figure 24. Argentina South & Central America Structural Heart Market Revenue and Forecast to 2028 (USD Million)
Figure 25. Rest of South & Central America South & Central America Structural Heart Market Revenue and Forecast to 2028 (USD Million)

The List of Companies – South & Central America Structural Heart Market

– Abbott Laboratories
– Medtronic Plc
– Boston Scientific Corp
– Artivion Inc
– Edwards Lifesciences Corp
– Braile Biomedica Industry, Commerce and Representations Ltd

Reviews

There are no reviews yet.

Be the first to review “South & Central America Structural Heart Market Forecast to 2028”